Vectibix
Topical Gel Relieves Painful Rash Caused by Anti-EGFR Therapies
A novel topical gel, LUT014 (Lutris Pharma), significantly reduced the severity of the acne-like rash, a common ...
APRIL 30, 2025
FDA Approves Lumakras With Vectibix for KRAS G12C–Mutated Colorectal Cancer
The FDA has approved sotorasib (Lumakras, Amgen) with panitumumab (Vectibix, Amgen) for adult patients with KRAS ...
JANUARY 21, 2025
Vectibix Approved for Wild-Type RAS Metastatic CRC
The FDA has approved panitumumab and companion diagnostic for patients with wild-type mCRC.
JULY 5, 2017
Load more